Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

Core Viewpoint - Biomerica, Inc. has launched the inFoods IBS Trigger Food Navigator, an AI-backed digital tool aimed at improving dietary compliance and treatment success for patients with Irritable Bowel Syndrome (IBS) [1][4]. Product Overview - The inFoods IBS test identifies an average of two to four specific foods that trigger IBS symptoms, allowing for a targeted dietary plan [2]. - The Trigger Food Navigator enhances this by providing smart meal suggestions, ingredient substitutions, and simplified meal planning tools [2][4]. Patient Benefits - The inFoods IBS test allows patients to maintain most of their current diet with minor adjustments, making it easier than traditional restrictive diets [3]. - The AI-backed Navigator empowers patients to manage their IBS symptoms effectively, leading to improved adherence to dietary plans and better symptom relief [4][15]. Clinical Results - A pivotal clinical study published in June 2025 showed that 59.6% of patients in the treatment group achieved significant abdominal pain reduction, compared to 42.2% in the control group [8][16]. - Among IBS-C patients, 67.1% in the treatment group achieved the endpoint versus 35.8% in the control group, and for IBS-M patients, 66.0% versus 29.5% [8][16]. Access and Integration - The Trigger Food Navigator is available at no additional cost for patients who have purchased the inFoods IBS test, with easy access through healthcare providers or online [9]. Company Background - Biomerica, Inc. is a global biomedical technology company focused on developing advanced diagnostic and therapeutic products, particularly for gastrointestinal and inflammatory diseases [10][11].